Period Ending | Dec 28, 2012 | Dec 30, 2011 |
---|
Total Revenue
|
18,339,000
|
18,655,000
| Cost of Revenue | 12,499,000 | 12,813,000 | |
Gross Profit
|
5,840,000
|
5,842,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
|
Selling General and Administrative | 3,029,000 | 3,016,000 |
|
Non Recurring | 141,000 | (2,000) |
|
Others |
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
| | |
Operating Income or Loss
|
2,670,000
|
2,828,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 41,000 | 55,000 |
|
Earnings Before Interest And Taxes | 2,711,000 | 2,883,000 |
|
Interest Expense | 258,000 | 7,000 |
|
Income Before Tax | 2,453,000 | 2,876,000 |
|
Income Tax Expense | 811,000 | 1,101,000 |
|
Minority Interest |
-
|
-
|
|
|
|
Net Income From Continuing Ops | 1,642,000 | 1,775,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
|
Extraordinary Items |
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
|
Other Items |
-
|
-
| | |
Net Income
|
1,642,000
|
1,775,000
| Preferred Stock And Other Adjustments |
-
|
-
| |
Net Income Applicable To Common Shares
|
1,642,000
|
1,775,000
|
|